Literature DB >> 17127293

Genetic polymorphism in bladder cancer.

Xifeng Wu1, Xin Lin, Colin P Dinney, Jian Gu, H Barton Grossman.   

Abstract

Individual variation in the genetic constitution of humans may affect the host responses to constant assaults from exogenous and endogenous carcinogens, which will eventually impact cancer risk, disease prognosis and clinical outcome. Bladder cancer is one of the most common cancers in the world. In this review, the published research articles studying the association between genetic polymorphisms and bladder cancer risk and disease progression are summarized. Genetic polymorphisms are categorized based on their primary cellular functions: genes in carcinogen metabolism, DNA repair, cell cycle control, inflammation, apoptosis, methylation, genes functioning as G proteins, and cell adhesion molecules. Furthermore, we discuss a number of limitations of current genetic susceptibility research and suggest future directions in molecular epidemiology study. This review presents an overview of current molecular epidemiology of bladder cancer and provides a useful resource for understanding the pathogenesis of bladder cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17127293     DOI: 10.2741/2058

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.

Authors:  Jie Lin; Jianming Wang; Anthony J Greisinger; H Barton Grossman; Michele R Forman; Colin P Dinney; Ernest T Hawk; Xifeng Wu
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-30

2.  Genetic susceptibility to bladder cancer risk and outcome.

Authors:  Jian Gu; Xifeng Wu
Journal:  Per Med       Date:  2011-05       Impact factor: 2.512

3.  The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans.

Authors:  Yanlei Du; Yu-Jui Yvonne Wan
Journal:  Alcohol Clin Exp Res       Date:  2009-09-17       Impact factor: 3.455

4.  Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

Authors:  Meng Chen; Adrian Cassidy; Jian Gu; George L Delclos; Fan Zhen; Hushan Yang; Michelle A T Hildebrandt; Jie Lin; Yuanqing Ye; Robert M Chamberlain; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

5.  Genetic variants in telomere-maintenance genes and bladder cancer risk.

Authors:  Joshua Chang; Colin P Dinney; Maosheng Huang; Xifeng Wu; Jian Gu
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis.

Authors:  Cao Wenjuan; Lu Jianzhong; Li Chong; Gao Yanjun; Lu Keqing; Wang Hanzhang; Wang Zhiping
Journal:  Int Braz J Urol       Date:  2016-09-01       Impact factor: 1.541

7.  Bladder cancer epidemiology and genetic susceptibility.

Authors:  Haiyan Chu; Meilin Wang; Zhengdong Zhang
Journal:  J Biomed Res       Date:  2013-03-25

8.  Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.

Authors:  Hua Wei; Ashish M Kamat; Saad Aldousari; Yuanqing Ye; Maosheng Huang; Colin P Dinney; Xifeng Wu
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology.

Authors:  Magdalena Traczyk; Edyta Borkowska; Marek Rożniecki; Rafał Purpurowicz; Adam Jędrzejczyk; Piotr Marks; Michał Pietrusiński; Zbigniew Jabłonowski; Marek Sosnowski; Bogdan Kałużewski
Journal:  Cent European J Urol       Date:  2012-06-12

10.  TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.

Authors:  Xiao Yang; Pengchao Li; Xuejian Yang; Chao Qin; Qiang Cao; Zhengdong Zhang; Meilin Wang; Hongzhou Cai; Jinbao Gu; Jun Tao; Min Gu; Qiang Lu; Changjun Yin
Journal:  Int J Genomics       Date:  2013-12-03       Impact factor: 2.326

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.